Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jacc.2020.06.039 http://scihub22266oqcxt.onion/10.1016/j.jacc.2020.06.039 32828614!7438071!32828614     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Am+Coll+Cardiol 2020 ; 76 (11): 1318-1324 Nephropedia Template TP {{tp|p=32828614|t=2020. Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China |pdf=|usr=}}{{32828614}} gab.com Text Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China JO: J Am Coll Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=32828614 #FOAvip BACKGROUND: ST-segment elevation myocardial infarction (STEMI) is a fatal cardiovascular emergency requiring rapid reperfusion treatment. During the coronavirus disease-2019 (COVID-19) pandemic, medical professionals need to strike a balance between providing timely treatment for STEMI patients and implementing infection control procedures to prevent nosocomial spread of COVID-19 among health care workers and other vulnerable cardiovascular patients. OBJECTIVES: This study evaluates the impact of the COVID-19 outbreak and China Chest Pain Center's modified STEMI protocol on the treatment and prognosis of STEMI patients in China. METHODS: Based on the data of 28,189 STEMI patients admitted to 1,372 Chest Pain Centers in China between December 27, 2019 and February 20, 2020, the study analyzed how the COVID-19 outbreak and China Chest Pain Center's modified STEMI protocol influenced the number of admitted STEMI cases, reperfusion strategy, key treatment time points, and in-hospital mortality and heart failure for STEMI patients. RESULTS: The COVID-19 outbreak reduced the number of STEMI cases reported to China Chest Pain Centers. Consistent with China Chest Pain Center's modified STEMI protocol, the percentage of patients undergoing primary percutaneous coronary intervention declined while the percentage of patients undergoing thrombolysis increased. With an average delay of approximately 20 min for reperfusion therapy, the rate of in-hospital mortality and in-hospital heart failure increased during the outbreak, but the rate of in-hospital hemorrhage remained stable. CONCLUSIONS: There were reductions in STEMI patients' access to care, delays in treatment timelines, changes in reperfusion strategies, and an increase of in-hospital mortality and heart failure during the COVID-19 pandemic in China. Twit Text FOAVip Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China ????J Am Coll Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=32828614 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32828614 #FOAvip English Wikipedia <ref>{{Cite pmid|32828614}}</ref> Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China #MMPMID32828614 Xiang D; Xiang X; Zhang W; Yi S; Zhang J; Gu X; Xu Y; Huang K; Su X; Yu B; Wang Y; Fang W; Huo Y; Ge J J Am Coll Cardiol 2020[Sep]; 76 (11): 1318-1324 PMID32828614show ga BACKGROUND: ST-segment elevation myocardial infarction (STEMI) is a fatal cardiovascular emergency requiring rapid reperfusion treatment. During the coronavirus disease-2019 (COVID-19) pandemic, medical professionals need to strike a balance between providing timely treatment for STEMI patients and implementing infection control procedures to prevent nosocomial spread of COVID-19 among health care workers and other vulnerable cardiovascular patients. OBJECTIVES: This study evaluates the impact of the COVID-19 outbreak and China Chest Pain Center's modified STEMI protocol on the treatment and prognosis of STEMI patients in China. METHODS: Based on the data of 28,189 STEMI patients admitted to 1,372 Chest Pain Centers in China between December 27, 2019 and February 20, 2020, the study analyzed how the COVID-19 outbreak and China Chest Pain Center's modified STEMI protocol influenced the number of admitted STEMI cases, reperfusion strategy, key treatment time points, and in-hospital mortality and heart failure for STEMI patients. RESULTS: The COVID-19 outbreak reduced the number of STEMI cases reported to China Chest Pain Centers. Consistent with China Chest Pain Center's modified STEMI protocol, the percentage of patients undergoing primary percutaneous coronary intervention declined while the percentage of patients undergoing thrombolysis increased. With an average delay of approximately 20 min for reperfusion therapy, the rate of in-hospital mortality and in-hospital heart failure increased during the outbreak, but the rate of in-hospital hemorrhage remained stable. CONCLUSIONS: There were reductions in STEMI patients' access to care, delays in treatment timelines, changes in reperfusion strategies, and an increase of in-hospital mortality and heart failure during the COVID-19 pandemic in China. |*Coronavirus Infections/epidemiology/prevention & control[MESH] |*Infection Control/methods/organization & administration[MESH] |*Pandemics/prevention & control[MESH] |*Percutaneous Coronary Intervention/methods/statistics & numerical data[MESH] |*Pneumonia, Viral/epidemiology/prevention & control[MESH] |*ST Elevation Myocardial Infarction/complications/mortality/therapy[MESH] |*Thrombolytic Therapy/methods/statistics & numerical data[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |China/epidemiology[MESH] |Coronary Angiography/methods/statistics & numerical data[MESH] |Female[MESH] |Heart Failure/epidemiology/etiology[MESH] |Hospital Mortality[MESH] |Hospitalization[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Organizational Innovation[MESH] |Outcome and Process Assessment, Health Care[MESH] |Patient Care/methods/trends[MESH]Management and Outcomes of Patients With STEMI During the COVID-19 Pan(epmc).pdf DeepDyve Pubget Overpricing